← brief for 2026-10-14 · Slowing decline

Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review.

Paper No results yet Peer reviewed

Key takeaways

This review looks at stomach and gut side effects from a class of diabetes and weight loss drugs. It explains why these side effects happen and how to manage them. It is a summary of existing studies, not a new trial. It helps patients and doctors understand common issues with these drugs.

Who did this work

Cisneros JZ · Camilleri M · Grover M

Source

Paper · PubMed, the drug frontier · 2026 Sep 30
https://pubmed.ncbi.nlm.nih.gov/42871863/